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ABSTRACT 
 
We have extended our previously developed 3D multi-scale agent-based brain tumor model to 
simulate cancer heterogeneity and to analyze its impact across the scales of interest. While our 
algorithm continues to employ an epidermal growth factor receptor (EGFR) gene-protein 
interaction network to determine the cells’ phenotype, it now adds an explicit treatment 
of  tumor cell adhesion related to the model’s biochemical microenvironment. We simulate a 
simplified tumor progression pathway that leads to the emergence of five distinct glioma cell 
clones with different EGFR density and cell ‘search precisions’. The in silico results show 
that microscopic tumor heterogeneity can impact the tumor system’s multicellular growth 
patterns. Our findings further confirm that EGFR density results in the more aggressive clonal 
populations switching earlier from proliferation-dominated to a more migratory phenotype. 
Moreover, analyzing the dynamic molecular profile that triggers the phenotypic switch 
between proliferation and migration, our in silico oncogenomics data display spatial and 
temporal diversity in documenting the regional impact of tumorigenesis, and thus support the 
added value of multi-site and repeated assessments in vitro and in vivo. Potential implications 
from this in silico work for experimental and computational studies are discussed.  
 
 
1. INTRODUCTION 
 
We present the extension of our previously developed three-dimensional (3D) agent-based, 
multi-scale brain tumor model to incorporate a simplified glioma progression pathway in an 
effort to study the impact of clonal heterogeneity on tumor growth dynamics. For the micro-
macroscopic environment, we expanded the initial setup [1-3] by simulating the interaction 
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between the chemoattractant concentration and the degree of cell adhesion. Like before [3], a 
set of chemoattractants such as glucose, oxygen tension and transforming growth factor alpha 
( αTGF ) diffuses [4-6] along a gradient that depends both on the initial conditions as well as 
on the cells’ consumption and secretion ( αTGF ). Also, the glioma cells’ considerably high 
migration rate in vivo, and even more so, in vitro [7] is impacted by the αTGF  concentration 
to properly reflect available experimental data [8-11]. Specifically, we modeled the 
chemotactically attracted cells as follows: once the concentration of the so called homotype 
attractant [12], in this case αTGF , substantially exceeds that of the heterotype attractant [13] 
such as glucose, the homotype attractant ( αTGF ) plays a much more important role for 
directing cell attraction and vice versa. For the molecular environment, each cell is equipped 
with an epidermal growth factor receptor (EGFR) gene-protein interaction pathway [1-3] that 
is implicitly integrated with a simplified cell cycle module [14]. The pathway molecule 
‘activated phospholipase Cγ’ (PLCγ) is critical in determining the cell phenotype which 
represents experimental results reported in part by [15] for the case of breast cancer. However, 
other than in our previous works where heterogeneity arose only from phenotypic alterations 
of an otherwise mono-clonal tumor, here, we have integrated a simplified cancer progression 
model (based on [16]) to generate a heterogeneous brain tumor that eventually consists of five 
distinct clonal populations that emerged through mutational events. These clones differ in 
their EGFR density in addition to being able to adjust their phenotypic behavior readily to the 
micro-environmental conditions. To properly reflect available experimental data, the sub-
clones with higher EGF receptor density are more aggressive [17], and operate with an 
inefficient metabolism [18, 19]; yet, they achieve a higher chemotactic search precision to 
move faster along the environment’s least resistance, most permission and highest attraction 
paths [20]. We will discuss the results and their potential implications, and introduce plans for 
future work. 
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2. PREVIOUS WORKS 
 
Earlier tumor models focused primarily either on the micro-macroscopic or on the molecular 
level to simulate tumor growth and migration. For instance, for the micro-macroscopic scale, 
Mansury et al. [21-23] proposed a two-dimensional (2D) agent-based model in which the 
spatio-temporal expansion of malignant brain tumor cells is guided by environmental 
heterogeneities (mechanical confinement, toxic metabolites and nutrient sources) in order to 
gain more insight into the systemic effect of such cellular chemotactic search precision 
modulations. For the molecular scale, Schoeberl et al. [24] built up a computational model to 
describe the dynamics of the MAPK cascade activated by EGF receptors and Araujo et al. 
[25] developed an EGFR signaling network model that not only shows the protein dynamics 
in the EGFR pathway but also predicts the therapeutic effect of inhibitors on the molecular 
network. In an effort to develop a cell cycle module, Alarcon et al. [14] extended the work of 
Tyson and Novak [26] to model the cancer cell cycle process under hypoxic conditions. 
Additionally, to simulate mutation among different clones, Sole and Deisboeck [16] revised 
the previous quasispecies model of Swetina and Schuster [27] to research the impact of 
genetic instability on tumor growth. While these models undoubtedly are useful at their 
particular scale of interest, the quest of studying the tumor as a biological system that crosses 
scales requires a multiscale modeling approach. Therefore, in [28] and [1, 2] our group 
developed a 2D multi-scale agent-based tumor model to integrate both, the molecular and 
micro-macroscopic environments. Specifically, in [1] we put forward an EGFR gene-protein 
interaction pathway in which activated PLCγ is employed to determine the cell phenotype. 
Subsequently, in [2] we then compared the biological behavior of glioma cell clones with 
varying EGFR density. Building on this work, in [3] we recently introduced a 3D multi-scale 
agent-based brain tumor model which explicitly includes a cell cycle description. However, 
this multi-scale model has a number of shortcomings that include simulating a monoclonal, 
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and thus a genetically stable tumor, and it also suffers from a rather simplistic description of 
the tissue microenvironment. In an effort to model these features more realistically the 
subsequent section will describe the setup of a much more sophisticated 3D multi-scale brain 
tumor model that includes explicitly the phenotype of cell adhesion as it relates to 
chemoattractant [10] and incorporates specifically the emergence of heterogeneous tumor cell 
clones.       
 
 
3. MATHEMATICAL MODEL 
 
As before, this multi-scale agent-based brain tumor model includes macro-microscopic and 
molecular environments that interact with each other. The following sections describe these 
environments and their relationships in detail.   
 
3.1.  Macro-microscopic environment 
3.1.1.  Clonal heterogeneity  
Here, a slice of virtual brain tissue is modeled with a 100*100*100 3D rectangular lattice as 
depicted in Figure 1. A continually replenished nutrient source, representing a blood vessel, 
is located in Cube 4.  
 
Figure 1 
 
To yield tumor heterogeneity, an element of genetic instability is introduced that is based on 
the mutation model presented by [16]. Our ‘progression pathway’ here incorporates five 
glioma cell clones (A, B, C, D and E) that emerge sequentially (Figure 2), and that are 
distinct in their EGFR receptor density. Based on experimental data, in our setup, cell clones 
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with higher EGFR receptor density are more aggressive [17, 29, 30] and operate with an 
inefficient metabolism [18, 19]; yet, they achieve a higher chemotactic search precision to 
move faster along the environment’s least resistance, most permission and highest attraction 
paths [20]. 
 
Figure 2  
 
In the beginning, five hundred clone A cells are initialized as close as possible to the center of 
the lattice as each cell occupies one lattice point. As a first iteration, the model implements a 
linear progression pathway in assuming that clone A can only mutate to B, clone B to C, C to 
D, and D to E. The respective mutation rates depend on the cell’s proliferation period and are 
listed in Table 1.  
 
Table 1 
 
To mimic progression from a relatively genetically stable precursor, we set the mutation rate 
from clone A to B as %10
Periodion ProliferatA 
Periodion Proliferat B1 =− . Applying the same calculation for the 
remaining clones, we deduce a mutation rate from B to C of 11%, from C to D of 12% and D 
to E of 15%. 
 
3.1.2.  Chemoattractants 
Transforming growth factor alpha ( αTGF ) is a protein that not only can affect the secreting 
tumor cell itself, hence generates an ‘autocrine’ feedback loop, but also can impact bystander 
cells, an effect known as ‘paracrine’. Habib et al. [12] refers to this soluble chemical effector 
as homotype chemoattractant. Conversely, glucose, not produced by tumor cells, is denoted as 
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heterotype attractants [13]. Our setup places a blood vessel in the center of Cube 4 to supply 
glucose, αTGF and oxygen for the developing brain tumor. Initially, these chemoattractants 
are dispersed by normal distribution described in Eq. 1-3: 
)/2exp( 221 tijkm
ijk dTX σ−⋅=                      (1) 
)/2exp()( 2214 gijkama
ijk dGGGX σ−⋅−+=                                           (2) 
 )/2exp()( 2244 oijkama
ijk dkkkk σ−⋅−+=                                (3) 
In Eq. 1, mT stands for the maximum αTGF  ( 1X ) concentration in the tumor [31] and tσ  is 
the parameter that controls the dispersion of the αTGF  level. In Eq. 2, aG  is the minimum 
blood glucose ( 14X ) level while mG  stands for the maximum concentration of glucose in 
blood, with gσ  being the parameter controlling the dispersion of glucose. Likewise, in Eq. 3, 
ak  is the minimum oxygen tension and mk  represents the maximum oxygen tension ( 44k ) [3, 
14], oσ  is the parameter controlling the dispersion of the oxygen tension level, and ijkd  is the 
L-infinity [21] distance to the center of Cube 4. During the simulation, at each time step the 
cell will take up glucose to maintain its metabolism and secrete αTGF  [1] triggering both 
paracrine and autocrine biological behavior that is described by Eq. 4-5:  
T
tt SXX += −111             (4) 
EDCBAnrXX n
tt ,,,,,11414 =−= −                                 (5) 
In Eq. 4-5, t  represents the time step, TS  is the αTGF  secretion rate [32] and nr  is the cell’s 
glucose uptake coefficient [33] for each clone. Because [19] argues that the metabolism of 
cancer cells is approximately eight times larger than the metabolism of normal cells and since 
[33] discovered that for U87 human glioma cells the glucose uptake rate is 0.77 pmol/h per 
cell, we assign each clone (A, B, C, D and E) a different glucose uptake rate related to its 
EGFR density, which is listed in the Table 2.  
Le Zhang et al.: Simulating Tumor Heterogeneity with a Multiscale Agent-Based Model 
 8
Table 2 
 
Because the chemo-attractants’ initialization through Eq. 1-3 causes different gradients in the 
3D lattice, the aforementioned biochemicals glucose, αTGF and oxygen will simultaneously 
diffuse [1-3] during the simulation according to Eq.6-8. 
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                                                       (8) 
where 1D  is the diffusion coefficient of glucose [5], 2D is the αTGF  diffusion coefficient [6] 
and oD stands for the diffusion coefficient of oxygen [4]. 
 
3.1.3.  Spatial search process 
Representing the biological mechanism of chemotaxis we have again implemented a search 
mechanism as put forward already in [21, 22]. 
 ED,C,B,A,,)1( =⋅−+⋅= nLT ijknijknijk εψψ       (9) 
where ijkT  stands for the perceived attractiveness of location (i,j,k), ijkL  represents the correct, 
non-erroneous evaluation of location (i,j,k) where ),(~ 2σµε Nj is an error term that is 
normally distributed with mean µ  and variance 2σ . The parameter nψ  is positive between 
zero and one, 10 ≤≤ nψ , and represents the extent of the ‘search precision’ (with ‘0’ 
exhibiting purely random walk behavior, and ‘1’ being fully biased without any error in signal 
processing); the subscript of ψ represents the different clones. In accordance with 
experimental data [29] that report an acceleration of the tumor’s spatio-temporal expansion 
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rate with increasing EGFR density per cell, we argue that a cancer cell with high EGFR 
density should express a comparably high search precision (being lesser affected by the noise 
function). Thus, we assign a search precision value of 0.5 for clone A and B, and 0.7 for clone 
C, D and E, respectively.    
 
The definitions of the Von Neumann and Moore neighborhoods [21] usually are restricted to 
2D lattices. We therefore define 3D Von Neumann neighborhood, 3D Diagonal neighborhood, 
and 3D Moore neighborhood as detailed in Eq.10-12 with 
⎪⎭
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Here, (x0 , y0 , z0) denotes the current location of the cell and (x ,y ,z) represents the 
coordinates of its neighborhood. We set the grid size to 10μm to reflect the (idealized) 
average diameter of a real tumor cell and each simulation step represents approximately 2.5 
hours, similar to our previous study [3]. The maximum distance for a given tumor cell to 
migrate under a 3D Von Neumann neighborhood search is therefore 10μm/simulation step, 
14.4μm/simulation step under a 3D Diagonal neighborhood search, and 17.3μm/simulation 
step under a 3D Moore neighborhood search paradigm, hence well within the range of the 
tumor cell migration rate reported in vitro [7].  
 
It has been well established that cancer cells differ from normal cells in a variety of ways 
which include uncontrolled proliferation, loss of contact inhibition, progressive lack of tumor 
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cell-tumor cell adhesion and tissue invasion [34]. Also, Athale and Deisboeck [2] already 
demonstrated in separate simulation runs that in silico, glioma cells with higher EGFR density 
are more aggressive with faster migration and lower proliferation rate. Moreover, as indicated 
by [8-11] the concentration of chemo-attractant can impact the degree of tumor cell adhesion 
and the cells’ migration rate. We therefore ranked the diffusive αTGF concentration at three 
levels in decreasing order: If the neighborhood of the tumor cell carries a high average αTGF  
concentration (= level 1) the cell can choose its next location from the 3D Moore 
neighborhood ( m zyxN ),,( 000 ) which conveys the highest spatial permission and therefore results 
in the fastest cell migration rate. If the cell resides at a location within the second αTGF  
concentration level (2), it will choose the next location from the 3D Diagonal neighborhood 
( d zyxN ),,( 000 ). Otherwise, the cell will select its next location from the more restrictive 3D Von 
Neumann neighborhood ( v zyxN ),,( 000 ). We therefore incorporate in our expanded model here not 
only that the chemotactically-driven search precision of clones C, D, E is higher than that of 
clones A and B. Rather, in addition, we implement that a higher αTGF concentration can 
increase the cell’s spatial “permission”, thus reflecting its progressive loss of tumor cell-tumor 
cell adhesion as reported in [8-11], and as such implicitly adding an element of haptotaxis.  
 
As discussed earlier, ijkL  is the correct, non-erroneous evaluation of location, which includes 
homotype and heterotype chemoattractants. Eq. 13 models this biological behavior, i.e., if a 
cell resides in location (x0 , y0 , z0) and the sum of its 3D Von Neumann neighborhood αTGF  
( ∑
v
zyxN
X
)0,0,0(
1 ) is greater than glucose concentration ( ∑
v
zyxN
X
)0,0,0(
14 ), then this cell is subjective to 
choose the homotype attractant, otherwise the cell is attracted by the heterotype cue.  
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3.1.4.   Cell phenotype  
As before, we simulate four different cellular phenotypes, i.e. migration, proliferation, 
quiescence and apoptosis – now, however, for each of the five different glioma cell clones. 
We again implement the concept of ‘dichotomy’ for glioma cells, first put forward by [35] 
which argues on the basis of mounting experimental data that migration and proliferation are 
mutually exclusive behaviors that can happen in sequence, yet hardly at the same time in the 
same cell. Using breast cancer cells, Dittmar et al. [15] discovered that PLCγ is activated 
transiently during cell migration. Building on this experimental data, Athale et al. [1, 2] and 
Zhang et al. [3] employ a PLCγ threshold ( PLCσ ) to model a hypothesized biological 
switching behavior in that PLCγ is activated to a greater extent during migration and more 
gradually during proliferation. Thus, the migration potential is assessed by a cell evaluating 
the following function: 
      ])([)][(
dt
PLCdPLCM n
γγ =                                     (14)  
where nM  is the migration potential that equals the change in concentration of active PLCγ 
over time and n is the cell number. Once nM  is greater than PLCσ , the cell chooses a 
migratory phenotype, otherwise it undergoes proliferation. We note that there are three 
possibilities that the cell enters the reversible quiescent state: (1) the cell is unable to find an 
empty location to migrate to or proliferate into; or (2) the migration potential ( nM ) is less 
than PLCσ  and sEGFRppTGF _−α  is less than EGFRσ ; or, (3) the glucose concentration 
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around the cell drops to critically low values. If the on-site glucose concentration diminishes 
even further, the cell enters an apoptotic state [36]. 
 
3.2.  Molecular environment 
The sub-cellular setup is described in detail in [3]. Here, we therefore only briefly summarize 
this molecular environment, focus on its modifications, and note that the model’s intracellular 
workflow is depicted in Figure 3.(a). Specifically, each cell is equipped with an EGFR gene-
protein interaction network shown in Figure 3.(b), which is composed of 14 molecular 
species in addition to the five molecular species involved in our simplified cell cycle 
representation as listed in Table 3. These molecular species interact with each other according 
to mass balance equations, denoted by the general form: 
   iiii
i XX
dt
dX βα −=                                  (15) 
where Xi is the mass of ith (i=1-14) molecules comprising the EGFR network and ii βα , (i=1-
14) are the rate of synthesis and degradation rate of EGFR pathway, respectively. Also, Xi 
(i=15-19) molecules are the components of the cell cycle and ii βα , (i=15-19) are the 
coefficients of the cell cycle module. The values of parameters and constants are listed in [3]. 
As an important extension of our previous works, a proliferation process has now been 
explicitly integrated into the model in that more aggressive cell clones are associated with a 
shorter cell doubling time. 
 
Figure 3 
Table 3 
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4. RESULTS 
 
Our code is implemented in Java (Sun Microsystems, Inc., USA), combined with in-house 
developed classes for representing molecules, reactions and multi-receptors as a set of 
hierarchical objects. Running the simulation 10 times with different random normal 
distribution, gσ , of glucose (Eq. 2), the algorithm requires a total of 70 hrs 46 min of CPU 
time on a computer with an IBM Bladecenter machine (dual-processor 32-bit Xeons ranging 
from 2.8-3.2GHz w/2.5GB RAM) and Gigabit Ethernet. Each node runs Linux with a 2.6 
kernel and Sun's J2EE version 1.5. 
 
Employing a multi-level growth model, our analysis spans several scales of interest in  
starting with the overall, macroscopic behavior followed by the multicellular population 
patterns before focusing on the distinct impact molecular-level dynamics have on microscopic 
cell phenotypes.  
 
Volumetric tumor growth dynamics: We measure the tumor system’s [total] volume by 
counting the number of lattice sites occupied by a tumor cell regardless of its phenotype, 
hence lumping together both proliferative- and migratory-driven expansion. Figure 4 shows 
the tumor’s volumetric increase over time for the 10 simulation runs. 
 
Figure 4 
 
To achieve a higher spatial resolution of analysis, we divide the macroscopic tumor into three 
microscopic regions, sectioning the distance between the tumor and the nutrient source such 
as shown in Figure 5.(a): region 1 is closest to the nutrient source, region 3 is farthest from 
the nutrient source, with region 2 being located in between.  
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Tumor heterogeneity: In an attempt to quantify clonal heterogeneity we employ the so-
called Shannon Index which is defined as ∑−=
i
ii ppH )ln( where ip is the frequency of 
clone i  within the tumor [37]. Figure 5.(b) displays this index for region 1, 2, and 3 at each 
time step. While the indices for all three regions generally increase (i.e., exhibit more clonal 
heterogeneity) region 1 experiences an unexpected drop around t = 100, which indicates the 
emergence of a more homogenous sub-section prior to a gain of clonal diversity similar to that 
of the other two geographic sub-regions.  
 
Figure 5 
 
Visualizing this type of emergent heterogeneity by orienting us on curve-crossing points seen 
in Figure 5.(b), we display in Figure 6.(a)-(c) representative 3D snapshots of the tumor at 
consecutive time points t = 105, 180 and 230. As one would expect from a chemotaxis-driven 
search, the tumor overall expands towards the location of the nutrient source (compare with 
Figure 1). 
 
Figure 6 
 
Expansion rate per tumor region: To support this impression quantitatively, we measure the 
expansion rate for each sub-region by computing the average expansion radius for each region 
based on its center of mass. The results show that tumor region 1, i.e., closest to the nutrient 
source, expands much faster than regions 2 and 3 that are farther from the nutrient source 
(Figure 7).  The lesser expansion rate of region 2 (versus region 3) is due to the fact that cells 
in region 2 find fewer empty locations to choose from.  
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Figure 7 
 
Expansion rate per tumor clone: The next question to address is then how much of that 
regional specificity is due to its prevailing clonal population and as such we measure the 
expansion rate for clone A, B, C, D and E at each time step by computing the average 
expansion radius for each clone based on the center of each clone. From Figure 8 one can see 
that clone E (with the highest EGFR density per cell) exhibits the highest expansion rate 
increase. In contrast, although clone A and B (with lower EGFR density) originate first, and 
thus also start to expand much earlier than clone C, D and E, these two lower malignant 
clones keep a much smaller expansion rate for most of the simulation. 
 
So far, the results support the notion that a higher density of the more aggressive clone E is 
responsible for the higher expansion rate increase in the tumor region that is closest to the 
nutrient source. This therefore warrants a more detailed look into the phenotypic dynamics of 
the cancerous clones in general, and of clone E in particular.  
 
Figure 8 
 
Phenotypic spectrum per tumor clone: Turning then to the microscopic analysis level by 
monitoring the phenotypic fractions of clone A, B, C, D and E at each time step (Figure 9. 
(a)-(e)) it is evident that clones with higher EGFR density are eventually comprised of a 
larger migratory fraction, while exhibiting a smaller proliferation and quiescence cell 
population. Specifically, clone E has the largest and most sustained migratory cell population, 
and, as the curve shows, the ‘population’ crossover between a more stationary, proliferation-
dominated to an expansive, migration-dominated clone happens earlier than in the other, less 
aggressive tumor clones. We also note that, qualitatively, the fluctuations in the curves 
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increase from a fairly periodic pattern in the lower malignant clones A and B, to a much less 
regular, ‘noisy’ pattern in the higher malignant clones. 
 
Figure 9 
Figure 10 
 
Molecular phenotype-switching profiles: Moving now to the sub-cellular level, and 
building on our previous study [3], we use a heatmap display to visualize the percentage 
change of each molecular component of the implemented EGFR network (Figure 3. (b)) 
when the cells switch their phenotype from migration to proliferation or from proliferation to 
migration. We focus on time points, t =200 and 230, i.e. when the simulation begins to show 
sustained migration for most of the clones and again, when the run is almost completed. From 
Figure 10 it is evident that no phenotype switching signature is exactly alike. That is, 
differences exists between time points, phenotype switches, and geographic regions. However, 
there are also some similarities as for most cases, the signals for dimeric EGFRTGF −α  cell 
surface complex ( 3X ), phosphorylated active dimeric EGFRTGF −α cell surface complex 
( 4X ), cytoplasmic inactive dimeric EGFRTGF −α  complex ( 5X ), cytoplasmic EGFR  
protein ( 6X ) and Ca-bound inactive γPLC  ( 10X ) experience a more profound dynamic 
change for each region.  
 
 
5. DISCUSSION & CONCLUSIONS 
 
In here, we present an expansion of our 3D multi-scale agent-based brain tumor model that 
has now been extended to (1) also incorporate an element of genetic instability to simulate 
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glioma progression and to analyze its impact across multiple scales. Building on our previous 
works [1-3], this model not only encompasses molecular, microscopic and macroscopic scales 
of observation, but now also integrates (2) both, cell doubling time and cell cycle into the 
cells’ proliferation module. (3) This model also simulates the impact of chemo-attractants on 
cancer cells adhesion and migration rate. In the following, we discuss the results in more 
detail. 
 
The tumor region adjacent to a blood vessel representing nutrient source (i.e., region 1) 
harbors early on the highest clonal heterogeneity (Figure 5.(b)), reflecting the spatio-temporal 
output of the implemented linear progression path. However, around time step t = 100 this 
geographic ‘tip’ region (Figure 6.(a)-(c)) becomes increasingly homogeneous due to a 
temporary competitive advantage of the most aggressive clone E with regards to its chemo-
sensing ability and high spatial expansion rate. During a period that is marked by variability 
across runs (increasing fluctuations in standard deviation), clone E prevails in its quest to 
move fastest into the direction of “(least resistance,) most permission and highest attraction” 
[20], and, in the process, impacting the spatio-temporal patterns of the entire tumor system. 
However, the micro-environmental conditions closer to the core of the tumor, i.e. for cells in 
regions 2 and 3 are less selective for clone E and thus continuous tumor progression yields a 
sustained increase in the Shannon Index that eventually even exceeds the peak value for 
region 1. One can argue that, other than region 1, regions 2 and 3 allow for an element of 
temporary coexistence if not cooperation between the clones. Since regions 2 and 3 together 
add up to a larger volume than region 1 alone, this finding corresponds well with another 
recent claim of cancer cell cooperation fostering tumorigenesis [38], and also with the results 
reported by [37] on esophagus cancer which indicated that clonal heterogeneity is a greater 
risk factor for progression to cancer than the expansion of a homogeneous clone with a low 
Shannon Index value. This is confirmed in our own results as clone E’s dominance of region 1 
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is relatively short-lived with the heterogeneity index soon returning to values comparable to 
the two proximal tumor regions. The question arises then as to what precisely are the effects 
of such clonal heterogeneity on tumor growth dynamics? First, due to their higher density of 
EGF receptors per cell, clones C, D and primarily E exhibit an increased expansion rate 
(Figure 8) over clones A and B. Correspondingly, Figure 9 confirms that these tumor clones 
with higher EGFR density switch earlier to an invasive phenotype-dominated cell population 
that operates with a larger fraction of migratory cells, yet with lesser proliferative and 
quiescent cells. Our in silico model shows that higher EGFR expression leads to faster 
expansion of tumor areas that harbor more such aggressive cell populations, in areas of 
nutrient abundance. This, in turn, will result in overall growth asymmetries (see region 1, 
Figure 7), i.e., findings that taken together correspond well with reported experimental and 
clinical results [17, 29, 30].  
 
Taking advantage of our algorithm’s multi-scale design we can analyze the molecular 
composition of the gene-protein interaction network at the location and time when the cell 
transitions from one phenotype to another. Specifically, Figure 10 demonstrates that there are 
both spatially and temporally distinct molecular signatures that lead to the cells’ phenotypic 
switch. Cautiously extrapolated to an orders of magnitude more complex experimental 
situation, one wonders how much more robust in vitro and in vivo expression profiles would 
have to be within a patient’s tumor (let alone across an entire patient population) to warrant 
the single site and time point assessments that are commonly used for functional genomics in 
clinics. In fact, applying a global genomic analysis Maher et al. [39] recently showed wide-
spread differences between primary and secondary glioblastoma entities and reported that the 
latter group (which develops over multiple years from lower malignant astrocytomas [40]) is 
heterogeneous in its molecular pathogenesis. Our findings should therefore not be 
misinterpreted as questioning the value of such high-throughput data, rather, our in silico 
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results argue that assessing the molecular profile repeatedly, and at different sites of the tumor, 
should add predictive power. Interestingly, we found that at time step 200 the percentage 
changes of some molecules (i.e., 3X , 4X , 5X , 6X  and 10X ) in region 2 and 3 is more 
substantial than in region 1 regardless of the switch per se. The reason for this is that the 
higher EGFR density in clones C-E results in higher concentrations of other downstream 
molecules as well. Hence, the relative molecular fluctuations should be lesser in clones C, D 
and E than in clones A and B. And, since region 1 is mostly comprised of cells derived from 
clones C-E, its molecular composite signature appears to be more preserved between the time 
points than that of the other two regions. However, over time many more aggressive cells 
originate from clones A and B also in the more proximal tumor regions, and we see therefore 
eventually a somewhat more homogeneously aggressive pattern where regions 2 and 3 start to 
resemble the distant region 1. As such, by monitoring the molecular signature dynamics per 
region, one can at least in silico visualize the gradual tumorigenic evolution of sub-regions of 
the tumor, in an effort to better understand how they may contribute to multicellular growth 
behavior.  
 
Despite these considerable extensions, our modeling platform of course has still a number of 
shortcomings that can and should be addressed in future works. For example, we currently 
rely on a fixed mutation rate between each clone and mutations only occur linearly from A to 
E, without any non-linear ‘shortcuts’ and without assigning different weight to specific 
mutations. In subsequent research, we intend to implement a dynamical mutation rate that 
depends both on intrinsic and extrinsic or microenvironmental factors. Other extensions on 
the molecular level will rely on sensitivity analysis, or may include a more explicit treatment 
of vascular architecture. Nonetheless, this work significantly enhances our previously 
introduced platform [1-3] by including the element of genetic instability and integrating both 
cell cycle and cell doubling time into the cells’ proliferation process. Given the fact that we 
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begin to be able to validate some of the model’s predictions with experimental studies, we 
firmly believe that this type of interdisciplinary approach holds significant promise to help 
improve our understanding of brain cancer progression and its impact on the tumor system’s 
regional and global growth dynamics.   
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CAPTIONS 
 
Figure 1. Schematic of 3D lattice, with Cube 4 harboring the nutrient source.  
 
Figure 2. The mutational steps that constitute the genetic progression pathway from clone A 
to E.  
 
Figure 3. (a) The cancer cell’s sub-cellular workflow that determines its phenotypic output. 
(b) The EGFR gene-protein interaction network (see text for details). 
 
Figure 4. The volume of the tumor system (y-axis) over time (x-axis). Shown are mean values 
of 10 simulation runs with random standard deviation (grey) of the glucose concentration at a 
range between 50 and 60 nmol/lattice site.  
 
Figure 5. (a) The schematic shows the separation of the tumor into three regions (dotted lines) 
with varying distance to the nutrient source (black circle in Cube 4; compare with Fig. 1). (b) 
Depicted is the Shannon Index (y-axis) over time (x-axis) for these three distinct regions. 
Shown is the result of 10 runs with standard deviation. 
  
Figure 6. 3D snapshots of the tumor system at time step t = 100 (a), t =180 (b), t = 230 (c). 
The red circle depicts the location of the nutrient source (compare with Fig. 1). Note, the light 
and dark green colors represent cells of clone A in their proliferation state and migration state, 
respectively; light and dark blue represent cells of clone B in proliferation and migration 
states; light and dark yellow represent cells of clone C in proliferation and migration state; 
light and dark purple represent cells of clone D in proliferation and migration states; light and 
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dark red represent cells of clone E in proliferation and migration states. Finally, light and dark 
grey represent cells in the quiescence and apoptosis states, respectively, for clones A-E.  
 
Figure 7. The expansion rate (y-axis) of regions 1, 2 and 3 over time (x-axis). 
 
Figure 8. The expansion rate (y-axis) of clone A, B, C, D and E over time (x-axis). 
 
Figure 9. The phenotypic spectrum (y-axis) for clone (a) A, (b) B, (c) C, (d) D and (e) E  
over time (x-axis).   
 
Figure 10. Percentage change of each EGFR network component (compare with Fig. 3(b)) 
combined to molecular signatures and represented as heatmaps, for the three geographic 
tumor regions, at time step 200 and 230, respectively. (Note: M → P = phenotypic switch 
from migration to proliferation; P → M = from proliferation to migration [3]).   
 
Table 1. Cell cycle times and proliferation periods for clone A to E. 
 
Table 2. Coefficients of the tumor heterogeneity model taken from the literature [1-3, 5, 6].  
 
Table 3: Symbols of the EGFR gene-protein interaction network and cell cycle module taken 
from the literature[3]. 
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FIGURE 3. (a)  
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FIGURE 5. (a) 
 
 
 
FIGURE 5. (b) 
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FIGURE 6. (a) 
 
 
FIGURE 6. (b) 
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FIGURE 7.  
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FIGURE 9. (a) 
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FIGURE 9. (c)  
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FIGURE 9. (d) 
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Figure 10.  
Heat map legend  
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TABLE 1.  
Clone type Cell cycle Proliferation period 
A T 2T 
B T 1.8T 
C T 1.6T 
D T 1.4T 
E T 1.2T 
 
 
TABLE 2. 
Ar  121085.3 −×  mol/step Glucose uptake coefficient for clone A 
Br  12104 −×  mol/step Glucose uptake coefficient for clone B 
Cr  12107.7 −×  mol/step Glucose uptake coefficient for clone C 
Dr  111054.1 −×  mol/step Glucose uptake coefficient for clone D 
Er  111008.3 −×  mol/step Glucose uptake coefficient for clone E 
1D  
7107.6 −×  12 −scm  Diffusion coefficient of glucose  
2D  
71018.5 −×  12 −scm  Diffusion coefficient of αTGF  
oD  
5108 −×  12 −scm  Diffusion coefficient of oxygen tension 
mT  18147 ±  mlpg /  Maximum concentration of αTGF  
aG  
91072.0 −×  mol/site Normal concentration of glucose 
mG  
91036.2 −×  mol/site Maximum concentration of glucose 
TS  0.3 molecules/min  Secretion rate of αTGF  
ak  0.0017 Dimensionless Constant (DC) 
Normal concentration of oxygen 
mk  0.0025 DC Maximum concentration of oxygen 
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TABLE 3. 
Symbol Variable 
1X  αTGF  extracellular protein 
2X  EGFR  cell surface receptor 
3X  Dimeric EGFRTGF −α  cell surface complex 
4X  Phosphorylated active dimeric EGFRTGF −α cell surface complex 
5X  Cytoplasmic inactive dimeric EGFRTGF −α  complex 
6X  Cytoplasmic EGFR  protein 
7X  Cytoplasmic αTGF  protein 
8X  EGFR RNA  
9X  αTGF RNA  
10X  γPLC  inactive , Ca-bound  
11X  γPLC  active, phosphorylated, Ca-bound 
12X  Nucleotide pool 
13X  Glucose cytoplasmic 
14X  Glucose extracellular 
15X  cdh1-APC complex 
16X  cyclin-CDK 
17X  Mass of the cell 
18X  Protein p27 
19X  RBNP 
 
